At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
Browsing: Emerging Disease
At the recent Microbiology Society Annual Conference (10–12 April, Birmingham, UK) we spoke to Mark Wass about his work on Ebolaviruses in which he’s delved into the molecular determinants of the virus’s pathogenicity.
Two cases of Ebola have been confirmed in Bikoro in the Democratic Republic of Congo, sparking a response from the government and the WHO.
Infectious diseases and population mobility are intimately linked from the perspectives of clinical practice to global health policy. Mobility bridges significant epidemiological differences in the classical determinants of health for all diseases. The new reality is that “surveillance, detection and response” activities in infectious diseases clinical care and public health are the responsibility all members of society.
A CDC report has shown that infection rates of diseases transmitted via the bite of an infected mosquito, tick or flea have tripled in the United States since the year 2004.
A new study has identified a common pattern of immune response in Ebola-infected monkeys 4 days prior to the development of fever; this response could be utilized as an early diagnosis biomarker.
Biothreats are in the limelight of the current military, scientific and medical debate. Although it is arguable whether they are a major impending risk, their political and societal relevance is out of discussion. They are one of the collective fears which characterize our epoch.